MHC class I molecules

[1]  B. Baker,et al.  MHC Allele-Specific Molecular Features Determine Peptide/HLA-A2 Conformations That Are Recognized by HLA-A2-Restricted T Cell Receptors1 , 2002, The Journal of Immunology.

[2]  Daniel Coombs,et al.  Supplementary information for Activated TCRs remain marked for internalization after dissociation from pMHC , 2022 .

[3]  F. Cainelli,et al.  Infections and solid organ transplant rejection: a cause-and-effect relationship? , 2002, The Lancet. Infectious diseases.

[4]  P. Moss,et al.  Cytomegalovirus Seropositivity Drives the CD8 T Cell Repertoire Toward Greater Clonality in Healthy Elderly Individuals1 , 2002, The Journal of Immunology.

[5]  R. Welsh,et al.  T cell immunodominance and maintenance of memory regulated by unexpectedly cross-reactive pathogens , 2002, Nature Immunology.

[6]  Raymond M. Welsh,et al.  No one is naive: the significance of heterologous T-cell immunity , 2002, Nature Reviews Immunology.

[7]  E. Petersdorf,et al.  Herpes simplex virus type 2-specific CD8 cytotoxic T lymphocyte cross-reactivity against prevalent HLA class I alleles. , 2002, Blood.

[8]  D. Briscoe,et al.  A rendezvous before rejection: Where do T cells meet transplant antigens? , 2002, Nature Medicine.

[9]  M. Salmon,et al.  EBV-Specific CD8+ T Cell Memory: Relationships Between Epitope Specificity, Cell Phenotype, and Immediate Effector Function1 , 2001, The Journal of Immunology.

[10]  V. Emery,et al.  Viral infections and their impact on chronic renal allograft dysfunction. , 2001, Transplantation.

[11]  P. Parham,et al.  The Repertoire of Killer Cell Ig-Like Receptor and CD94:NKG2A Receptors in T Cells: Clones Sharing Identical αβ TCR Rearrangement Express Highly Diverse Killer Cell Ig-Like Receptor Patterns1 , 2001, The Journal of Immunology.

[12]  J. Ortaldo,et al.  The Virus-Specific and Allospecific Cytotoxic T-Lymphocyte Response to Lymphocytic Choriomeningitis Virus Is Modified in a Subpopulation of CD8+ T Cells Coexpressing the Inhibitory Major Histocompatibility Complex Class I Receptor Ly49G2 , 2000, Journal of Virology.

[13]  R. Welsh,et al.  Evolution of the CD8 T-cell repertoire during infections. , 2000, Microbes and infection.

[14]  H. Rammensee,et al.  The Role of Peptides in T Cell Alloreactivity Is Determined by Self–Major Histocompatibility Complex Molecules , 2000, The Journal of experimental medicine.

[15]  D. Speiser,et al.  In Vivo Expression of Natural Killer Cell Inhibitory Receptors by Human Melanoma–Specific Cytolytic T Lymphocytes , 1999, The Journal of experimental medicine.

[16]  S. L. Silins,et al.  The influence of antiviral T-cell responses on the alloreactive repertoire. , 1999, Immunology today.

[17]  S. Burrows,et al.  Direct alloreactivity by human cytotoxic T lymphocytes can Be inhibited by altered peptide ligand antagonism. , 1999, Blood.

[18]  P. Ljungman,et al.  Risk factors for chronic graft-versus-host disease after bone marrow transplantation: a retrospective single centre analysis , 1998, Bone Marrow Transplantation.

[19]  R. Germain,et al.  Relationships among TCR ligand potency, thresholds for effector function elicitation, and the quality of early signaling events in human T cells. , 1998, Journal of immunology.

[20]  R. Germain,et al.  T-cell signaling: The importance of receptor clustering , 1997, Current Biology.

[21]  V. Engelhard,et al.  Alloreactive cytotoxic T lymphocytes focus on specific major histocompatibility complex-bound peptides. , 1997, Transplantation.

[22]  J. McCluskey,et al.  Cross‐reactive memory T cells for Epstein‐Barr virus augment the alloresponse to common human leukocyte antigens: degenerate recognition of major histocompatibility complex‐bound peptide by T cells and its role in alloreactivity , 1997, European journal of immunology.

[23]  J. Burrows,et al.  An alloresponse in humans is dominated by cytotoxic T lymphocytes (CTL) cross-reactive with a single Epstein-Barr virus CTL epitope: implications for graft-versus-host disease , 1994, The Journal of experimental medicine.

[24]  D. Wiley,et al.  Comparison of the P2 specificity pocket in three human histocompatibility antigens: HLA-A*6801, HLA-A*0201, and HLA-B*2705. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[25]  P. Bjorkman,et al.  Thermal stability comparison of purified empty and peptide-filled forms of a class I MHC molecule. , 1992, Science.

[26]  Dean R. Madden,et al.  The three-dimensional structure of HLA-B27 at 2.1 Å resolution suggests a general mechanism for tight peptide binding to MHC , 1992, Cell.

[27]  D. Wiley,et al.  HLA-A2-peptide complexes: refolding and crystallization of molecules expressed in Escherichia coli and complexed with single antigenic peptides. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[28]  R. Balderas,et al.  T-cell receptor alpha-chain variable-region haplotypes of normal and autoimmune laboratory mouse strains. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[29]  C. Barnstable,et al.  Production of monoclonal antibodies to group A erythrocytes, HLA and other human cell surface antigens-new tools for genetic analysis , 1978, Cell.

[30]  R. Lechler,et al.  The molecular basis of alloreactivity. , 1990, Immunology today.

[31]  F. Miedema,et al.  Anti‐HLA‐class II monoclonal antibodies inhibit polyclonal B cell differentiation in vitro at the accessory cell level , 1987, European journal of immunology.